Request Deal Involvement

Atlas Venture, Bain Capital Life Sciences and RTW Investments led a $400m Series A round in Kailera Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Principals

KAILERA THERAPEUTICS

target

KAILERA THERAPEUTICS

RTW INVESTMENTS

bidder

RTW INVESTMENTS

ATLAS VENTURE LP

bidder

ATLAS VENTURE LP

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

LYRA CAPITAL

bidder

LYRA CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite